Blog

16 October, 2019

The pharmaceutical industry strengthens its commitment to pediatric clinical research and already promotes nine out of ten trials in this field

Farmaindustria participates in Santiago de Compostela in the II National Meeting of the Spanish Network of Pediatric Clinical Trials Source: www.farmaindustria.es The research and development of […]
3 October, 2019

More hospitals aspire to become CAR-T centers

Source: IM Medical Publimas Digital s.l. The Ministry of Health and the Autonomous Communities have met to assess the suitability of new candidates to administer this […]
30 September, 2019

New drugs in cardiovascular disease, a success story

The pharmaceutical industry currently has about 600 new treatments against developing cardiovascular pathologies This Sunday, September 29, World Heart Day is celebrated Source: www.farmaindustria.es Cardiovascular diseases […]
16 September, 2019

The pharmaceutical industry develops in Spain almost 200 clinical trials on lung cancer

The European Week of this tumor has been celebrated, of which almost 30,000 new cases are diagnosed each year in Spain Despite being one of the […]
10 September, 2019

Pharmaceutical companies reaffirm their commitment to research and access to innovation in Spain

Predictability, adequate taxation and imagination in the search for solutions, within the framework of a constant dialogue with the Administration, keys to ensure the advancement of […]
29 July, 2019

A global and long-term analysis of the medication is essential to consider all its health, economic and social benefits

Impact on patient health, health system management and economic growth, among the most relevant effects The director of the Department of Pharmaceutical Studies, Pedro Luis Sánchez, […]
22 July, 2019

Each year 15,000 patients participate in clinical trials promoted by the pharmaceutical industry in Spain

Each year 15,000 patients participate in clinical trials promoted by the pharmaceutical industry in Spain Source: www.farmaindustria.es Spain has become one of the reference countries in […]
18 July, 2019

“Spanish society should know that participating in a clinical trial is something beneficial”

Farmaindustria participates in the program ‘Es la Tarde de Dieter’, by EsRadio, in a debate on clinical research in Spain Source: www.farmaindustria.es Clinical trials, which are […]
16 July, 2019

Pharmaceutical companies, managers, healthcare professionals and researchers seek to strengthen the excellence of clinical trials in Spain

Farmaindustria brings together in Madrid more than 120 experts to continue advancing in an area in which our country is already an international benchmark Source: www.farmaindustria.es […]
24 June, 2019

The pharmaceutical industry facilitates the participation of more than 150,000 patients in clinical trials in the last 12 years

More than half of the clinical research with medicines is done in the early stages, the most complex Strengthen the participation of patients in all stages […]
17 June, 2019

Private healthcare already participates in half of clinical trials

Specifically, they collaborate in 48.5 percent of them according to Farmaindustria data Source: www.sanidadprivada.publicacionmedica.com Between 2004 and 2018, private health centers have participated in 1,431 clinical […]
11 June, 2019

Spain takes a step forward in clinical research in early phases in pediatrics and rare diseases

Farmaindustria is working on a new online Guide for Early Phase Clinical Research Units for the benefit of the research community The University Hospital La Paz […]
30 May, 2019

CAR-T therapy, future option to improve the treatment of multiple myeloma

The day ‘Controversies in patients with myeloma: candidate or not to haematopoietic transplantation and in relapse’, organized by the Jiménez Díaz Foundation and the San Carlos […]
27 May, 2019

The resignation of May dilates the concern of the pharmaceutical companies before a Brexit without agreement

After almost three years at the head of the Government, Theresa May has announced that she will present her resignation on June 7. Source: www.consalud.es This […]
24 May, 2019

Clinical trials, key to developing new drugs and valuable for the economy and cost savings health

Source: www.farmaindustria.es Each new drug that reaches patients has one behind or, in general, several successful clinical trials. The clinical trial, which in the vast majority […]
24 May, 2019

Savings of 10,000 euros / patient for the clinical trials of the industry

Source: www.redaccionmedica.com The clinical trials promoted by the pharmaceutical industry “are not only vital to develop new treatments for patients, but also play an important role […]
24 May, 2019

Conference “University research and regulatory compliance of the RGPD”

Source: www.farmaindustria.es Scientific research in general, and biomedical research in particular, are activities of general public interest, given the benefits they bring to society as a […]
2 May, 2019

An atlas at the individual cell level will improve precision medicine in breast cancer

It reveals the diversity of cancer and immune cells in the tumor ecosystem, with the aim of better selecting treatments. Source: immedicohospitalario.es Investigadores University of Zurich […]
29 April, 2019

The protection of intellectual property, key to the development of new medicines

Source: immedicohospitalario.es The regulatory ecosystem for the protection of intellectual property in Europe works. The set of laws, regulations and incentives developed by the European Union […]
12 April, 2019

New agenda of the Aemps: management by objectives and supply plan

Source: Redaccionmedica.com The Spanish Agency of Medicines and Health Products has presented its Strategic Plan 2019-2022 that includes a total of 11 measures that aim to […]
11 April, 2019

Clinical trials provide a positive economic impact on the NHS

Source: Immedicohospitalario.es The carrying out of clinical trials in Spanish hospitals and research centers has very positive consequences for the agents involved. For the health system, […]
9 April, 2019

Spain, before a historic opportunity in the commitment to clinical trials

Source: Farmaindustria.es Have highly qualified, motivated and experienced professionals, have the ability to achieve patient participation and have processes digitized as electronic medical records. These are […]
19 March, 2019

Roche launches a clinical trials platform focused on the needs of patients

Source: actasanitaria.com The pharmaceutical company Roche has announced the launch of a new platform for clinical trials that is designed with the needs of patients throughout […]
15 March, 2019

The Association of Pharmaceutical Industry discusses counterfeit medicines

Source: actasanitaria.com On March 14, the 39th Symposium of the Spanish Association of Pharmaceutical Industry (AEFI) began in Barcelona, ??under the theme ‘Tracings and in contact […]
13 March, 2019

Promote R & D, ensure access and measure results, keys to the future in oncological drugs

Source: actasanitaria.com During a debate at the 7th Forum of the Foundation for Excellence and Quality of Oncology (ECO) held in Madrid, the president of Farmaindustria, […]
12 March, 2019

The pharmaceutical industry has doubled its investment in clinical research in Spain since 2005

Source: farmaindustria.es In less than three decades Spain has experienced an unprecedented advance in biomedical research, to be placed in the group of countries with better […]
7 March, 2019

The AEMPS explains how to apply for the temporary exemption for batch control in the United Kingdom

Source: actasanitaria.com The Spanish Agency for Medicines and Healthcare Products (AEMPS) has informed about the possibility of requesting the temporary exemption from the obligation to carry […]
27 February, 2019

First criteria to offer T-CAR therapies; Health figure “between 5 and 7” reference hospitals

Source: diariomedico.com This Tuesday the institutional working group of the plan on T-CAR therapies in the SNS meets. At the entrance of the meeting, the Minister […]
25 February, 2019

Javier Urzay, deputy director of Farmaindustria: “We want to turn Spain into one of the most attractive places in the world to do biomedical research”

Source: Farmaindustria.es “In this country we have a first-line healthcare system, well-trained health professionals, excellent research centers, committed patient organizations and pioneering legislation in Europe. Along […]
22 February, 2019

The effective participation of patients, essential for the success of clinical trials

Source: Farmaindustria.es Representatives of the Spanish Agency of Medicines and Health Products, research teams, pharmaceutical industry and patient organizations agree on the opportunity and need to […]